In February, over 250 engaged participants, leading voices from the ecosystem, and outstanding exhibitors gathered at Novum Research Park for a full day with a focus on MedTech. The result? A day filled with knowledge, ideas, and new connections where the importance of MedTech for healthcare, competitiveness, and society was at the center – and where Flemingsberg showed itself at its best as a meeting place for Life Science.
A future life science cluster isn’t built in a year – but with a solid foundation and the courage to act, important steps can be taken along the way. In February 2025, we launched Life Science Cluster Flemingsberg: a multifaceted project with powerful, interconnected ambitions – to enable Flemingsberg’s life science cluster to reach its full potential by collaboration and creating the right conditions for the establishment and growth of those who drive innovation – small and medium-sized enterprises – and, in doing so, contribute to the Stockholm region’s leading position within the sector.
At The Park Novum, you’re met with spacious offices, creative spaces, and a sweeping view over a growing Flemingsberg. Here, entrepreneurs, innovators, and researchers can find a home that not only provides a modern workplace, but also the opportunity to grow together.
The new 8,000 m² innovation center brings together 700 experts who push the boundaries of future solutions in energy, food, pharma and marine transport every day. An investment that truly shows how important Swedish industrial expertise, open collaborations and continued R&D are – not only for Alfa Laval, but for the whole of Europe.
On November 12 1975, the first allogeneic bone marrrow transplantation in Sweden was performed at Huddinge Hospital, here in Flemingsberg. On November 12 1975, the first allogeneic stem cell transplantation in Sweden was performed at Huddinge Hospital, here in Flemingsberg. From nuclear catastrophe the foundations of bone marrow transplantation had emerged, and with it, the birth of modern stem cell therapy — the same principles that today underpin cell and gene therapies and CAR-T treatments.
With the goal of supporting academia, healthcare, and industry in developing the cell and gene therapies of the future, OptiCell Solutions established its operations in Flemingsberg last year. The company has now entered into a research collaboration with Karolinska Institutet, marking a significant step in the desired direction.
On November 5, the doors to The Park Novum opened – a new co-working space in Novum Research Park. The festivities came with a Halloween theme, and gathered over 150 participants who celebrated together.
A letter of intent has been signed between the Karolinska ATMP Center and the ATMP Center Uppsala to deepen collaboration in the field of advanced therapies (ATMP). The initiative was celebrated with a joint kick-off at the end of October, where hopes for new research breakthroughs and benefits for patients were in focus.
With a background as a researcher at Karolinska Institutet and experience from academia, industry, and networking, Angela Hoyer, the new Networks and Event Manager at the Flemingsberg Science Foundation, is passionate about developing the life science sector. In her new role, Angela looks forward to creating meeting places where collaborations can grow, while also contributing to Flemingsberg’s continued development as a strong international hub for research and innovation.
With a clear message of hope for the future and a powerful spirit of collaboration, the Karolinska ATMP Center in Flemingsberg was inaugurated at the end of August. The center is a collaboration between Karolinska Institutet and Karolinska University Hospital and will serve as a national resource for the production of advanced therapies (ATMPs), where research, clinical trials, and treatments work seamlessly together to deliver groundbreaking therapies to patients.